Kedrion Biopharma · 11 hours ago
Global Market Access Lead (SR Director)
Fort Lee, NJ
Full-time
Hybrid
Director/Executive
10+ years expKedrion Biopharma, a global leader in plasma-derived therapies, is seeking a dynamic, experienced, and motivated Global Market Access Lead. In this senior role, you will lead the development and execution of U.S.-focused market access strategies while driving engagement with payers and stakeholders to maximize patient access to therapies.
Health Care
Responsibilities
Lead Access Strategy: Develop and implement market access strategies with a primary focus on the U.S., while ensuring alignment and scalability across global pipeline and marketed therapies
Shape Payer Value Propositions: Create compelling U.S. payer value propositions, define evidence requirements, and ensure integration into global development and launch strategies in collaboration with cross-functional teams
Engage Payer Stakeholders: Build and maintain strong relationships with U.S. public and private payers, PBMs, insurers, policy makers, and patient organizations, while also engaging global payers and HTA bodies to champion Kedrion’s therapies and secure favorable coverage, formulary positioning, and reimbursement
Support Launch Readiness: Drive U.S. access-related pre-launch planning and execution, including payer engagement, pricing support, and value communications, while contributing to Ex-U.S. launch and geographic expansion strategies
Gather and Apply Insights: Synthesize payer and HTA insights into actionable recommendations, identifying risks and opportunities to inform current and future strategies
Deliver Strategic Impact: Provide senior leadership with clear perspectives on the U.S. access environment and global market access trends that influence corporate strategy and long-term growth
Inform Clinical Development: Provide strategic access input to clinical programs to ensure evidence generation meets the needs of U.S. / global payers and HTA bodies
Advance Evidence Generation: Oversee HEOR and Real-World Evidence initiatives including cost-effectiveness analyses, budget impact models, and systematic reviews to support U.S. and global value communication in coordination with global marketing, global medical affairs and other key internal stakeholders
Monitor Market Access Trends: Track global market access trends, competitor activities, and healthcare policy changes, with particular attention to U.S. reimbursement and policy dynamics
Support HTA Engagement: Lead or support planning and submission activities for EU Joint Clinical Assessment (JCA) and other major HTA processes, ensuring strong alignment with U.S. access strategies and successful execution
Collaborate Cross-Functionally: Partner with regional Market Access, commercial, regulatory, and medical teams to align global strategies with local execution
Ensure Scientific Excellence: Drive the generation and publication of high-quality access-related data in peer-reviewed journals and at scientific conferences
Build and Lead Teams: Develop and mentor a high-performing global Market Access function capable of delivering measurable outcomes while operating as a player / coach
Qualification
Required
Bachelor's degree required; advanced degree (Master's, PhD, PharmD, MPH, or MBA) strongly preferred
At least 10 years of progressive experience in Market Access leadership positions within the biotech/pharma sector, with significant U.S. market access experience, ideally for novel therapies, rare diseases or specialty biologics including plasma derived or infused therapies
Deep expertise in U.S. payer systems, reimbursement pathways, and policy environments, with strong working knowledge of global payer systems and HTA processes across major markets (U.S., UK/EU, and ICON regions). Proven success in developing payer value propositions, evidence strategies, and access plans leading to positive reimbursement outcomes
Demonstrated success engaging external stakeholders, including U.S. payers, PBMs, HTA bodies, and health authorities
Excellent leadership, communication, and cross-functional collaboration skills
Demonstrated ability to think strategically, anticipate payer needs, and innovate in evidence generation and value demonstration
Proven ability to influence and advocate across diverse internal and external stakeholder groups
Domestic and international travel will be required
Preferred
Advanced degree (Master's, PhD, PharmD, MPH, or MBA) strongly preferred
Experience with HTA submissions (including EU JCA or equivalent) strongly preferred
Experience in rare diseases, hematology, immunology, or neurology preferred
Company
Kedrion Biopharma
Kedrion Biopharma is a manufacturer of blood and plasma derived products.
1001-5000 employees
Funding
Current Stage
Late StageTotal Funding
unknownKey Investors
Permira
2022-09-01Private Equity
2002-01-01Private Equity
Leadership Team
Akos Toth
CFO | Accounting, Finance and Controlling Director
Bob Rossilli
Chief Commercial Officer (CCO)
Recent News
PharmiWeb
2025-11-27
Company data provided by crunchbase